Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11% on-year to Rs 233 crore for the third quarter ended Dec. 31, 2024. The drug firm had reported a profit of Rs 210 crore in the October-December period of last fiscal.
Revenue from operations stood at Rs 1,146 crore in the third quarter compared to Rs 1,105 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.
Shares of the company settled 1.64 per cent higher at Rs 2,670.70 apiece on the BSE.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
